The objective of Project 3 is to define novel molecular pathways that controi adipocyte differentiation and function. Elucidating signaling pathways that govern adipocyte differentiation and triglyceride storage in adipose tissue pathways is expected to uncover new opportunities for therapeutic intervention in human metabolic disease. During the current grant period, we discovered three previously uncharacterized proteins that control lipid metabolism in adipocytes (TLE3, PSPC1, and IDOL). Building on our work in the current grant period, we propose a series of molecular, cell biological, and mouse studies to investigate hypotheses regarding the roles of these novel regulatory factors in physiology and disease.
Specific Aim 1 is to elucidate the mechanism of action of TLE3 in white versus brown adipose tissue phenotypic specification. We have discovered that mice overexpressing TLE3 in adipose tissue show profound alterations in adipocyte function, including a phenotypic shift from brown to white adipose tissue. Shifting white adipose tissue towards a more brown character is associated with improved metabolism and resistance to diabetes. A better understanding ofthe molecular pathways that control adipocyte phenotype would be highly significant and may have therapeutic implications.
Specific Aim 2 is to determine the function and mechanism of action of the putative RNA-binding protein PSPC1 in adipocyte differentiation. PSPC1 was identified along with TLE3 in our initial high-throughput cDNA screen as a new promoter of adipocyte differentiation. Deciphering the mechanism of action of this novel factor is likely to uncover new modes of action for regulatory factors in the control of adipocyte gene expression.
Specific Aim 3 is to define the role of the LXR-IDOL axis in triglyceride metabolism and lipid storage. Preliminary analysis of Idol knockout mice points to an unexpected function in the control of triglyceride metabolism and lipid storage. We hypothesize that LXR-dependent regulation of IDOL in adipose tissue is an important determinant of peripheral lipoprotein receptor activity and that IDOL provides a mechanism to link alterations in diet and sterol metabolism to lipid uptake and metabolism in these tissues.
Altered adipose tissue function or mass is associated with cardiovascular metabolic disease, underscoring the fundamental importance of adipocytes in metabolism. Elucidating signaling pathways that govern adipocyte differentiation and triglyceride storage in adipose tissue pathways is expected to uncover new opportunities for therapeutic intervention in human metabolic diseases (e.g., obesity, diabetes mellitus).
|Beigneux, Anne P; Fong, Loren G; Bensadoun, André et al. (2015) GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding. Circ Res 116:624-32|
|Bensadoun, André; Mottler, Charlene D; Pelletier, Chris et al. (2014) A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase. Biochim Biophys Acta 1841:970-6|
|Csaki, Lauren S; Dwyer, Jennifer R; Li, Xia et al. (2014) Lipin-1 and lipin-3 together determine adiposity in vivo. Mol Metab 3:145-54|
|Turlo, Kirsten; Leung, Calvin S; Seo, Jane J et al. (2014) Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter. Biochim Biophys Acta 1841:963-9|
|Goulbourne, Chris N; Gin, Peter; Tatar, Angelica et al. (2014) The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries. Cell Metab 19:849-60|
|Sha, Haibo; Sun, Shengyi; Francisco, Adam B et al. (2014) The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism. Cell Metab 20:458-70|
|Zhang, Peixiang; Verity, M Anthony; Reue, Karen (2014) Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle. Cell Metab 20:267-79|
|Adeyo, Oludotun; Allan, Bernard B; Barnes 2nd, Richard H et al. (2014) Palmoplantar keratoderma along with neuromuscular and metabolic phenotypes in Slurp1-deficient mice. J Invest Dermatol 134:1589-98|
|Plengpanich, Wanee; Young, Stephen G; Khovidhunkit, Weerapan et al. (2014) Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain. J Biol Chem 289:19491-9|
|Jiang, Haibo; Goulbourne, Chris N; Tatar, Angelica et al. (2014) High-resolution imaging of dietary lipids in cells and tissues by NanoSIMS analysis. J Lipid Res 55:2156-66|
Showing the most recent 10 out of 62 publications